References
- Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. CMAJ. 2009;181(9):E181–E190. doi:10.1503/cmaj.080612.
- Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013.
- Engelkes M, de Ridder MA, Svensson E, et al. Multinational cohort study of mortality in patients with asthma and severe asthma. Respir Med. 2020;165:105919. doi:10.1016/J.RMED.2020.105919.
- Engelkes M, Janssens HM, de Jongste JC, et al. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396–407. doi:10.1183/09031936.00075614.
- Backman H, Stridsman C, Hedman L, et al. Determinants of severe asthma - a long-term cohort study in Northern Sweden. J Asthma Allergy. 2022;15:1429–1439. doi:10.2147/JAA.S376806.
- Arnold DH, Gebretsadik T, Abramo TJ, et al. The RAD score: a simple acute asthma severity score compares favorably to more complex scores. Ann Allergy Asthma Immunol. 2011;107(1):22–28. doi:10.1016/j.anai.2011.03.011.
- Moons KGM, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or disagnosis (TRIPOD): explanantion and elaboration. Ann Intern Med. 2015;162(1):W1–73. doi:10.7326/M14-0698.
- Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128–138. doi:10.1097/EDE.0b013e3181c30fb2.
- Cox DR. Note on grouping. J Am Stat Assoc. 1957;52(280):543–547. doi:10.1080/01621459.1957.10501411.
- de Hond AAH, Steyerberg EW, van Calster B. Interpreting area under the receiver operating characteristic curve. Lancet Digit Health. 2022;4(12):e853–e855. doi:10.1016/s2589-7500(22)00188-1.
- Fitzpatrick AM, Szefler SJ, Mauger DT, et al. Development and initial validation of the asthma severity scoring system (ASSESS). J Allergy Clin Immunol. 2020;145(1):127–139. doi:10.1016/J.JACI.2019.09.018.
- Ramspek CL, Jager KJ, Dekker FW, et al. External validation of prognostic models: what, why, how, when and where? Clin Kidney J. 2021;14(1):49–58. doi:10.1093/ckj/sfaa188.